abstract |
The present invention relates to an antibody that specifically reacts with hDlk-1 and has an antitumor activity in vivo (anti-hDlk-1 antibody), a fragment of the antibody, a hybridoma that produces the antibody, the antibody or antibody fragment and a drug, And a pharmaceutical composition containing the antibody, a tumor therapeutic agent, a tumor angiogenesis inhibitor, a tumor diagnostic agent, a tumor detection method, a tumor detection and / or diagnostic kit, and the like. |